It’ll be interesting to see Startup Health’s next analysis of where the VC money went in Q2. My guess would be telehealth: Carbon Health lands $23m for a partly virtual offering.
As if enough opioids weren’t prescribed already, Practice Fusion got busted for taking payments from a pharmaceutical company to build a pain alert tool to encourage physicians to provide more.
Atul Gawande is no longer CEO of Amazon-JP Morgan-Berkshire Hathaway health startup Haven. If any kind of sea change happens in the US healthcare industry – and we need it to – it’s going to come from outsiders. But I’m not discouraged by this change. Is being CEO of this venture the best contribution Atual Gawande can make to changing healthcare? Probably not, because being CEO is about far more than having a vision and a medical background.
More consumer tech pressed into COVID-19 monitoring: Mount Sinai deploys Google Nest cameras for remote monitoring. The bad boys of big tech are helping in other ways too, with Amazon involved in multiple COVID-19 related projects.
While the cost of care keeps going up, the lack of competition means hospitals can keep passing on the cost of their inefficiency: 88% of the days first surgery is delayed. I’m guessing if most of the first surgeries are delayed, so are all the others that day. Because if OR’s aren’t running at a high utilization, then we have another problem all together.
I mentioned Tissue Analytics a couple of issues ago. It just got swallowed by a specialist EHR vendor Net Health. That’s OK, but Net Health is owned by private equity groups. I’m not thrilled about private equity getting involved in healthcare. Lack of transparency is a big problem driving healthcare costs higher. Private equity just adds another layer of obscurity since their financials aren’t public at all. Bloomberg has a nice piece that digs deeper into some of the consequences of PE’s move into the healthcare industry. Where there’s a fat margin to be found, private equity goes. If anything, private equities’ growing presence in the healthcare industry is a sure sign that the healthcare industry is more divorced than ever from the practice of medicine.
In a COVID-19 related development, Banner Health introduces virtual waiting rooms and chatbots to its appointment check-in process. Which is great, but I have to wonder: If the healthcare industry was as competitive as it could be, innovations like this might have happened long ago, purely as a way to gain a competitive business advantage.
As the pandemic makes temperature monitoring desirable, so vital sign monitoring companies are looking to fill that hole in their solutions where necessary: Current Health partners with VivaLNK to do just that.
BreatheVision is about to start a trial of its respiration rate monitoring device at the Sourasky Medical Center’s Ichilov Hospital.
Pakistan brings female doctors who are out of the workforce back into action for remote monitoring.
As the pandemic forces changes to healthcare access, so the spotlight has returned once again to the lack of interoperability restricting access to patient data. It’s been a basic competitive strategy of the software industry forever. If you’re already the dominant player, the best way to retain and grow your customer base is to make it hard for customers to migrate to a competitor’s system. That includes locking up the data. That works until somebody else big has a more open approach and can change that. Like Apple. Because Apple’s growth path is to expand the number of consumers using its devices. The growth path for EHR vendors is to expand the number of hospital systems usings their software. Patients aren’t even in the equation. For Apple, letting customers carry their medical records around on their phone grows customer loyalty. For dominant EHR vendors, open access to data is not in their best interests…